Monash University researchers, alongside key partner Halozyme Therapeutics, report findings in support of shifting the way ...
The FDA has granted approval to a larger vial size of nelarabine injection (SH-111) for use in treatment of adult and ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering ...
Byrdie on MSN
Meet the new class of injectables
Hollywood’s favorite new injectables are peptides and NAD+, but what do these treatments actually do?
New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime insulin to improve glycemic control.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results